Target intelligence / Profile preview

Heat shock 70 kDa protein 9-Tumor protein p53 protein-protein interaction interface (Mortalin-p53 PPI) (Mortalin-p53 PPI)

Target
Mortalin-p53 PPI
Molecular classification
Protein-protein interaction interface, Heat shock protein family, Tumor suppressor complex
01

Overview

The Heat shock 70 kDa protein 9-Tumor protein p53 protein-protein interaction interface is a critical regulatory site where the mitochondrial chaperone Mortalin (HSPA9) binds to the tumor suppressor protein p53. In many cancer cells, Mortalin is overexpressed and sequesters p53 in the cytoplasm, preventing its translocation to the nucleus and thereby inhibiting its ability to induce apoptosis or cell cycle arrest (Wadhwa et al., 1998, PubMed: 9694799). This interaction effectively inactivates the p53 pathway even in cells where the TP53 gene is wild-type. Therapeutic strategies targeting this interface aim to disrupt the complex using small molecules or natural compounds, such as Mortaparib or Withaferin A, thereby restoring p53's transcriptional activity and promoting cancer cell death (Wadhwa et al., 2002, PubMed: 12140244; Elakehal et al., 2020, PubMed: 32824534). While promising, targeting this interface presents challenges, including the need for high specificity to avoid disrupting Mortalin's essential roles in mitochondrial protein import and general proteostasis (UniProt: P38646). Early inhibitors like MKT-077 demonstrated proof-of-concept but were limited by systemic toxicities, leading to the development of more refined molecules like Mortaparib.

Other names
HSPA9-TP53 interactionGRP75-p53 complexPBP74-p53 interactionMortalin-p53 binding interfaceMitochondrial heat shock protein 70-p53 interaction
02

Mechanism of action

Disruption of the physical association between Mortalin (HSPA9) and p53, which prevents the cytoplasmic sequestration of p53 and allows its translocation to the nucleus to activate tumor-suppressive gene expression.

03

Biological functions

Apoptosis regulationCell cycle arrestProtein sequestrationMitochondrial protein importProteostasis
04

Disease associations

CancerHepatocellular carcinomaBreast cancerColorectal cancerNeurodegenerative disease
05

Safety considerations

Mitochondrial dysfunctionRenal toxicityDisruption of essential chaperone functionsOff-target effects on other HSP70 family members
06

Interacting drugs

MKT-077

6 more in the full profile.

07

Biomarkers

HSPA9 (Mortalin) expression levelsCytoplasmic p53 localizationNuclear p53 accumulationp21 (WAF1) expression

Beyond the preview

Go deeper on Heat shock 70 kDa protein 9-Tumor protein p53 protein-protein interaction interface (Mortalin-p53 PPI) (Mortalin-p53 PPI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock 70 kDa protein 9-Tumor protein p53 protein-protein interaction interface (Mortalin-p53 PPI) (Mortalin-p53 PPI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call